Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.

Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...

Healthcare conglomerate Johnson & Johnson kicked off its bankruptcy plan confirmation Tuesday, in its third attempt to resolve one of the largest mass tort lawsuits through an affiliate it placed into ...